Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis

Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia

(2012) Maynika V. Rastogi et al.   PEDIATRIC BLOOD & CANCER

How I treat childhood CML

(2011) J. R. Andolina et al.   BLOOD

Applicability of Greulich and Pyle skeletal age standards to Indian children

(2011) Sumit T. Patil et al.   FORENSIC SCIENCE INTERNATIONAL

Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial

(2011) Frédéric Millot et al.   JOURNAL OF CLINICAL ONCOLOGY

Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia

(2011) Haruko Shima et al.   JOURNAL OF PEDIATRICS

Imatinib has adverse effect on growth in children with chronic myeloid leukemia

(2011) Deepak Bansal et al.   PEDIATRIC BLOOD & CANCER

Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy

(2010) Susan L. Hobernicht et al.   PEDIATRIC BLOOD & CANCER

Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib

(2009) H. Schmid et al.   HAEMATOLOGICA

Growth deceleration in a girl treated with imatinib

(2009) Tomiko Kimoto et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Decreased Bone Turnover Despite Persistent Secondary Hyperparathyroidism during Prolonged Treatment with Imatinib

(2009) Susannah O'Sullivan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Imatinib mesylate causes growth plate closure in vivo

(2009) K Vandyke et al.   LEUKEMIA

Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?

(2009) L. Kebapcilar et al.   MEDICAL PRINCIPLES AND PRACTICE

Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy

(2009) Francesco Torino et al.   Nature Reviews Clinical Oncology

Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop

(2008) P. Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty

(2008) Stefania Mariani et al.   LANCET